{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:23:47Z","timestamp":1790742227761,"version":"4.1.0"},"reference-count":58,"publisher":"Becaris Publishing Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Comp. Eff. Res."],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:p>Despite significant controversy, vaginal laser therapy continues to be used for treatment of many gynecologic and pelvic conditions including vaginal atrophy, vaginal dryness, dyspareunia, urinary incontinence and pelvic pain. This commentary reviews the controversy surrounding vaginal laser therapy and summarizes the important distinction between ablative and non-ablative vaginal lasers. While much research is still needed, the article describes what is important for healthcare professionals to know before making the decision to integrate this technology into their clinical practice.<\/jats:p>","DOI":"10.2217\/cer-2021-0281","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T08:43:25Z","timestamp":1655801005000},"page":"843-851","source":"Crossref","is-referenced-by-count":25,"title":["Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here"],"prefix":"10.57264","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-0006","authenticated-orcid":false,"given":"Ralph","family":"Zipper","sequence":"first","affiliation":[{"name":"Zipper Urogynecology &amp; Associates, Melbourne, FL, 32935 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8427-0707","authenticated-orcid":false,"given":"Georgine","family":"Lamvu","sequence":"additional","affiliation":[{"name":"University of Central Florida College of Medicine, Department of Clinical Sciences, Obstetrics and\u00a0Gynecology, Orlando, FL, 32827\u00a0USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"36897","reference":[{"issue":"2","key":"e_1_3_3_3_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5978\/islsm.14-OR-11","article-title":"Treatment of vaginal relaxation syndrome with an erbium:YAG laser using 90 degrees and 360 degrees scanning scopes: a pilot study &and short-term results","volume":"23","author":"Lee MS","year":"2014","unstructured":"Lee MS. Treatment of vaginal relaxation syndrome with an erbium:YAG laser using 90 degrees and 360 degrees scanning scopes: a pilot study &and short-term results. Laser Ther. 23(2), 129\u2013138 (2014).","journal-title":"Laser Ther."},{"issue":"2","key":"e_1_3_3_4_2","first-page":"97","article-title":"Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause","volume":"67","author":"Gambacciani M","year":"2015","unstructured":"Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol. 67(2), 97\u2013102 (2015).","journal-title":"Minerva Ginecol."},{"issue":"5","key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3109\/13697137.2015.1045485","article-title":"Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause","volume":"18","author":"Gambacciani M","year":"2015","unstructured":"Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 18(5), 757\u2013763 (2015).","journal-title":"Climacteric"},{"issue":"3","key":"e_1_3_3_6_2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.maturitas.2014.12.006","article-title":"Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser","volume":"80","author":"Perino A","year":"2015","unstructured":"Perino A, Calligaro A, Forlani A Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 80(3), 296\u2013301 (2015).","journal-title":"Maturitas"},{"issue":"6","key":"e_1_3_3_7_2","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2017.09.003","article-title":"CO2 laser treatment is effective for symptoms of vaginal atrophy","volume":"198","author":"Anger JT","year":"2017","unstructured":"Anger JT. CO2 laser treatment is effective for symptoms of vaginal atrophy. J. Urol. 198(6), 1228\u20131229 (2017).","journal-title":"J. Urol."},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2147\/IJWH.S136857","article-title":"Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women","volume":"9","author":"Arroyo C","year":"2017","unstructured":"Arroyo C. Fractional CO2 laser treatment for vulvovaginal atrophy symptoms and vaginal rejuvenation in perimenopausal women. Int. J. Womens Health 9, 591\u2013595 (2017).","journal-title":"Int. J. Womens Health"},{"issue":"3","key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/GME.0000000000000761","article-title":"Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors","volume":"24","author":"Gambacciani M","year":"2017","unstructured":"Gambacciani M, Levancini M. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 24(3), 316\u2013319 (2017).","journal-title":"Menopause"},{"key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2017.01.012","article-title":"Laser therapy for the restoration of vaginal function","volume":"99","author":"Gambacciani M","year":"2017","unstructured":"Gambacciani M, Palacios S. Laser therapy for the restoration of vaginal function. Maturitas 99, 10\u201315 (2017).","journal-title":"Maturitas"},{"issue":"11","key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.jsxm.2017.09.004","article-title":"Low-level laser therapy for the treatment of provoked vestibulodynia \u2013 a randomized, placebo-controlled pilot trial","volume":"14","author":"Lev-Sagie A","year":"2017","unstructured":"Lev-Sagie A, Kopitman A, Brzezinski A. Low-level laser therapy for the treatment of provoked vestibulodynia \u2013 a randomized, placebo-controlled pilot trial. J. Sex. Med. 14(11), 1403\u20131411 (2017).","journal-title":"J. Sex. Med."},{"issue":"1","key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/GME.0000000000000955","article-title":"Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women","volume":"25","author":"Cruz VL","year":"2018","unstructured":"Cruz VL Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 25(1), 21\u201328 (2018).","journal-title":"Menopause"},{"issue":"1","key":"e_1_3_3_13_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5978\/islsm.18-OR-04","article-title":"Early effect of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy","volume":"27","author":"Eder SE","year":"2018","unstructured":"Eder SE. Early effect of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy. Laser Ther. 27(1), 41\u201347 (2018).","journal-title":"Laser Ther."},{"issue":"9","key":"e_1_3_3_14_2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/lsm.22940","article-title":"Fractional CO2 laser treatment for vaginal laxity: a preclinical study","volume":"50","author":"Kwon TR","year":"2018","unstructured":"Kwon TR Fractional CO2 laser treatment for vaginal laxity: a preclinical study. Lasers Surg. Med. 50(9), 940\u2013947 (2018).","journal-title":"Lasers Surg. Med."},{"key":"e_1_3_3_15_2","unstructured":"FDA. Statement from FDA commissioner Scott Gottlieb M.D. on efforts to safeguard women's health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for \u2018vaginal rejuvenation\u2019 (2018). www.fda.gov\/news-events\/press-announcements\/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims (Accessed 3 August 2021)."},{"key":"e_1_3_3_16_2","unstructured":"ACOG. Fractional laser treatment of vulvovaginal atrophy and US Food and Drug Administration clearance (2018). www.acog.org\/clinical-information\/policy-and-position-statements\/position-statements\/2018\/fractional-laser-treatment-of-vulvovaginal-atrophy-and-us-food-and-drug-administration-clearance (Accessed 3 August 2021)."},{"issue":"3","key":"e_1_3_3_17_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00192-018-3830-0","article-title":"IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity","volume":"30","author":"Shobeiri SA","year":"2019","unstructured":"Shobeiri SA IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int. Urogynecol. J. 30(3), 371\u2013376 (2019).","journal-title":"Int. Urogynecol. J."},{"issue":"2","key":"e_1_3_3_18_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/LGT.0000000000000462","article-title":"The clinical role of laser for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document","volume":"23","author":"Preti M","year":"2019","unstructured":"Preti M The clinical role of laser for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document. J. Low Genit. Tract. Dis. 23(2), 151\u2013160 (2019).","journal-title":"J. Low Genit. Tract. Dis."},{"issue":"10","key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1097\/GME.0000000000001577","article-title":"Vaginal laser treatment of genitourinarysyndrome of menopause: does the evidence support the FDA safety communication?","volume":"27","author":"Guo JZ","year":"2020","unstructured":"Guo, JZ et al.Vaginal laser treatment of genitourinarysyndrome of menopause: does the evidence support the FDA safety communication?. Menopause. 27(10), 1177\u20131184 (2020).","journal-title":"Menopause"},{"issue":"8","key":"e_1_3_3_20_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/lsm.23084","article-title":"Lasers and energy-based devices marketed for vaginal rejuvenation: a cross-sectional analysis of the MAUDE database","volume":"51","author":"Ahluwalia J","year":"2019","unstructured":"Ahluwalia J, Avram MM, Ortiz AE. Lasers and energy-based devices marketed for vaginal rejuvenation: a cross-sectional analysis of the MAUDE database. Lasers Surg. Med. 51(8), 671\u2013677 (2019).","journal-title":"Lasers Surg. Med."},{"issue":"2","key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/GME.0000000000001661","article-title":"Vaginal energy-based devices: characterization of adverse events based on the last decade of MAUDE safety reports","volume":"28","author":"Wallace SL","year":"2020","unstructured":"Wallace SL, Sokol ER, Enemchukwu EA. Vaginal energy-based devices: characterization of adverse events based on the last decade of MAUDE safety reports. Menopause 28(2), 135\u2013141 (2020).","journal-title":"Menopause"},{"issue":"5","key":"e_1_3_3_22_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/SPV.0000000000000872","article-title":"Vaginal energy-based devices","volume":"26","author":"Alshiek J","year":"2020","unstructured":"Alshiek J Vaginal energy-based devices. Female Pelvic. Med. Reconstr. Surg. 26(5), 287\u2013298 (2020).","journal-title":"Female Pelvic. Med. Reconstr. Surg."},{"issue":"1","key":"e_1_3_3_23_2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10103-021-03315-z","article-title":"Evaluation of a novel deep tissue transvaginal near-infrared laser and applicator in an ovine model","volume":"7","author":"Zipper R","year":"2021","unstructured":"Zipper R, Pryor B. Evaluation of a novel deep tissue transvaginal near-infrared laser and applicator in an ovine model. Lasers Med. Sci. 7(1), 639\u2013643 (2021).","journal-title":"Lasers Med. Sci."},{"issue":"3","key":"e_1_3_3_24_2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/nau.23931","article-title":"The clinical role of laser for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document","volume":"38","author":"Preti M","year":"2019","unstructured":"Preti M The clinical role of laser for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document. Neurourol. Urodyn. 38(3), 1009\u20131023 (2019).","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3889\/oamjms.2018.058","article-title":"Early regenerative modifications of human postmenopausal atrophic vaginal mucosa following fractional CO2 laser treatment","volume":"6","author":"Salvatore S","year":"2018","unstructured":"Salvatore S Early regenerative modifications of human postmenopausal atrophic vaginal mucosa following fractional CO2 laser treatment. Open Access Maced. J. Med. Sci. 6(1), 6\u201314 (2018).","journal-title":"Open Access Maced. J. Med. Sci."},{"issue":"1","key":"e_1_3_3_26_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10103-014-1677-2","article-title":"Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment","volume":"30","author":"Zerbinati N","year":"2015","unstructured":"Zerbinati N Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med. Sci. 30(1), 429\u2013436 (2015).","journal-title":"Lasers Med. Sci."},{"issue":"1","key":"e_1_3_3_27_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/GME.0000000000001416","article-title":"A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial","volume":"27","author":"Paraiso MFR","year":"2020","unstructured":"Paraiso MFR A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET trial. Menopause 27(1), 50\u201356 (2020).","journal-title":"Menopause"},{"issue":"8","key":"e_1_3_3_28_2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/GME.0000000000001542","article-title":"Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial","volume":"27","author":"Ruanphoo P","year":"2020","unstructured":"Ruanphoo P, Bunyavejchevin S. Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial. Menopause 27(8), 858\u2013863 (2020).","journal-title":"Menopause"},{"issue":"8","key":"e_1_3_3_29_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/lsm.23220","article-title":"Efficacy of fractional CO2 laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial","volume":"52","author":"Aguiar LB","year":"2020","unstructured":"Aguiar LB Efficacy of fractional CO2 laser, promestriene, and vaginal lubricant in the treatment of urinary symptoms in postmenopausal women: a randomized clinical trial. Lasers Surg. Med. 52(8), 713\u2013720 (2020).","journal-title":"Lasers Surg. Med."},{"issue":"3","key":"e_1_3_3_30_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.34172\/jlms.2020.49","article-title":"The effect of the CO2 fractional laser or premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial","volume":"11","author":"Eftekhar T","year":"2020","unstructured":"Eftekhar T The effect of the CO2 fractional laser or premarin vaginal cream on improving sexual function in menopausal women: a randomized controlled trial. J. Lasers Med. Sci. 11(3), 292\u2013298 (2020).","journal-title":"J. Lasers Med. Sci."},{"issue":"14","key":"e_1_3_3_31_2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jama.2021.14892","article-title":"Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial","volume":"326","author":"Li FG","year":"2021","unstructured":"Li FG Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial. JAMA 326(14), 1381\u20131389 (2021).","journal-title":"JAMA"},{"issue":"3","key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jsxm.2021.12.010","article-title":"CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis","volume":"19","author":"Filippini M","year":"2022","unstructured":"Filippini M CO2-laser therapy and genitourinary syndrome of menopause: a systematic review and meta-analysis. J. Sex Med. 19(3), 452\u2013470 (2022).","journal-title":"J. Sex Med."},{"key":"e_1_3_3_33_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.maturitas.2021.06.005","article-title":"Vaginal laser therapy for genitourinary syndrome of menopause \u2013 systematic review","volume":"156","author":"Mension E","year":"2021","unstructured":"Mension E Vaginal laser therapy for genitourinary syndrome of menopause \u2013 systematic review. Maturitas 156, 37\u201359 (2021).","journal-title":"Maturitas"},{"issue":"1","key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10103-021-03260-x","article-title":"A randomized controlled study of vaginal fractional CO2 laser therapy for female sexual dysfunction","volume":"37","author":"Lou W","year":"2021","unstructured":"Lou W A randomized controlled study of vaginal fractional CO2 laser therapy for female sexual dysfunction. Lasers Med. Sci. 37(1), 359\u2013367 (2021).","journal-title":"Lasers Med. Sci."},{"issue":"1","key":"e_1_3_3_35_2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10103-021-03305-1","article-title":"The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial","volume":"37","author":"Sathaworawong A","year":"2021","unstructured":"Sathaworawong A The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial. Lasers Med. Sci. 37(1), 581\u2013588 (2021).","journal-title":"Lasers Med. Sci."},{"issue":"11","key":"e_1_3_3_36_2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/1471-0528.16273","article-title":"Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review","volume":"127","author":"Mackova K","year":"2020","unstructured":"Mackova K Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG 127(11), 1338\u20131346 (2020).","journal-title":"BJOG"},{"issue":"1","key":"e_1_3_3_37_2","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1080\/13697137.2019.1703940","article-title":"Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis\/bladder pain syndrome: a case series (UNICORN-2 study)","volume":"23","author":"Okui N","year":"2020","unstructured":"Okui N, Okui M, Vizintin Z. Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis\/bladder pain syndrome: a case series (UNICORN-2 study). Climacteric 23(Supp1.), S14\u2013S17 (2020).","journal-title":"Climacteric"},{"issue":"4","key":"e_1_3_3_38_2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.23736\/S1973-9087.17.04432-X","article-title":"Effects of low-level laser therapy on pain in patients with musculoskeletal disorders: a systematic review and meta-analysis","volume":"53","author":"Clijsen R","year":"2017","unstructured":"Clijsen R Effects of low-level laser therapy on pain in patients with musculoskeletal disorders: a systematic review and meta-analysis. Eur. J. Phys. Rehabil. Med. 53(4), 603\u2013610 (2017).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"issue":"5","key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/acupmed-2015-011036","article-title":"Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials","volume":"34","author":"Glazov G","year":"2016","unstructured":"Glazov G, Yelland M, Emery J. Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials. Acupunct. Med. 34(5), 328\u2013341 (2016).","journal-title":"Acupunct. Med."},{"issue":"3","key":"e_1_3_3_40_2","first-page":"241","article-title":"Low-level laser therapy for fibromyalgia: a systematic review and meta-analysis","volume":"22","author":"Yeh SW","year":"2019","unstructured":"Yeh SW Low-level laser therapy for fibromyalgia: a systematic review and meta-analysis. Pain Physician 22(3), 241\u2013254 (2019).","journal-title":"Pain Physician"},{"issue":"4","key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/pho.2015.9848","article-title":"Low-level light\/laser therapy versus photobiomodulation therapy","volume":"33","author":"Anders JJ","year":"2015","unstructured":"Anders JJ, Lanzafame RJ, Arany PR. Low-level light\/laser therapy versus photobiomodulation therapy. Photomed. Laser Surg. 33(4), 183\u2013184 (2015).","journal-title":"Photomed. Laser Surg."},{"issue":"5","key":"e_1_3_3_42_2","doi-asserted-by":"crossref","DOI":"10.15406\/mojor.2015.02.00068","article-title":"The use of low level laser therapy (LLLT) for musculoskeletal pain","volume":"2","author":"Cotler HB","year":"2015","unstructured":"Cotler HB The use of low level laser therapy (LLLT) for musculoskeletal pain. MOJ Orthop. Rheumatol. 2(5), 2015).","journal-title":"MOJ Orthop. Rheumatol."},{"issue":"2","key":"e_1_3_3_43_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0014-5793(95)00763-Y","article-title":"Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase","volume":"369","author":"Brown GC","year":"1995","unstructured":"Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369(2-3), 136\u2013139 (1995).","journal-title":"FEBS Lett."},{"issue":"7114","key":"e_1_3_3_44_2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/443901a","article-title":"Cell biology: power games","volume":"443","author":"Lane N","year":"2006","unstructured":"Lane N. Cell biology: power games. Nature 443(7114), 901\u2013903 (2006).","journal-title":"Nature"},{"issue":"3","key":"e_1_3_3_45_2","doi-asserted-by":"crossref","DOI":"10.1109\/JSTQE.2016.2561201","article-title":"Proposed mechanisms of photobiomodulation or low-level light therapy","volume":"22","author":"de Freitas LF","year":"2016","unstructured":"de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J. Sel. Top. Quantum Electron. 22(3), (2016).","journal-title":"IEEE J. Sel. Top. Quantum Electron."},{"issue":"3","key":"e_1_3_3_46_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3934\/biophy.2017.3.337","article-title":"Mechanisms and applications of the anti-inflammatory effects of photobiomodulation","volume":"4","author":"Hamblin MR","year":"2017","unstructured":"Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 4(3), 337\u2013361 (2017).","journal-title":"AIMS Biophys."},{"issue":"2","key":"e_1_3_3_47_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10439-011-0454-7","article-title":"The nuts and bolts of low-level laser (light) therapy","volume":"40","author":"Chung H","year":"2012","unstructured":"Chung H The nuts and bolts of low-level laser (light) therapy. Ann. Biomed. Eng. 40(2), 516\u2013533 (2012).","journal-title":"Ann. Biomed. Eng."},{"issue":"2","key":"e_1_3_3_48_2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/lsm.23255","article-title":"Photobiomodulation therapy is able to modulate PGE2 levels in patients with chronic non-specific low back pain: a randomized placebo-controlled trial","volume":"53","author":"Tomazoni SS","year":"2021","unstructured":"Tomazoni SS Photobiomodulation therapy is able to modulate PGE2 levels in patients with chronic non-specific low back pain: a randomized placebo-controlled trial. Lasers Surg. Med. 53(2), 236\u2013244 (2021).","journal-title":"Lasers Surg. Med."},{"issue":"2","key":"e_1_3_3_49_2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jop.12204","article-title":"Anti-inflammatory effect of 635 nm irradiations on in vitro direct\/indirect irradiation model","volume":"44","author":"Lim W","year":"2015","unstructured":"Lim W Anti-inflammatory effect of 635 nm irradiations on in vitro direct\/indirect irradiation model. J. Oral Pathol. Med. 44(2), 94\u2013102 (2015).","journal-title":"J. Oral Pathol. Med."},{"issue":"9","key":"e_1_3_3_50_2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s10103-017-2346-z","article-title":"Effects of photobiomodulation therapy and topical non-steroidal anti-inflammatory drug on skeletal muscle injury induced by contusion in rats-part 1: morphological and functional aspects","volume":"32","author":"Tomazoni SS","year":"2017","unstructured":"Tomazoni SS Effects of photobiomodulation therapy and topical non-steroidal anti-inflammatory drug on skeletal muscle injury induced by contusion in rats-part 1: morphological and functional aspects. Lasers Med. Sci. 32(9), 2111\u20132120 (2017).","journal-title":"Lasers Med. Sci."},{"issue":"6","key":"e_1_3_3_51_2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/lsm.20516","article-title":"Low-level laser therapy for zymosan-induced arthritis in rats: importance of illumination time","volume":"39","author":"Castano AP","year":"2007","unstructured":"Castano AP Low-level laser therapy for zymosan-induced arthritis in rats: importance of illumination time. Lasers Surg. Med. 39(6), 543\u2013550 (2007).","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"e_1_3_3_52_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-016-2091-8","article-title":"Effects of photobiomodulation therapy, pharmacological therapy, and physical exercise as single and\/or combined treatment on the inflammatory response induced by experimental osteoarthritis","volume":"32","author":"Tomazoni SS","year":"2017","unstructured":"Tomazoni SS Effects of photobiomodulation therapy, pharmacological therapy, and physical exercise as single and\/or combined treatment on the inflammatory response induced by experimental osteoarthritis. Lasers Med. Sci. 32(1), 101\u2013108 (2017).","journal-title":"Lasers Med. Sci."},{"issue":"1","key":"e_1_3_3_53_2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12974-020-1703-1","article-title":"Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception","volume":"17","author":"Jang Y","year":"2020","unstructured":"Jang Y, Kim M, Hwang SW. Molecular mechanisms underlying the actions of arachidonic acid-derived prostaglandins on peripheral nociception. J. Neuroinflammation 17(1), 30 (2020).","journal-title":"J. Neuroinflammation"},{"key":"e_1_3_3_54_2","volume-title":"StatPearls.","author":"Ghlichloo I","year":"2021","unstructured":"Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: StatPearls. FL, USA (2021). www.ncbi.nlm.nih.gov\/books\/NBK547742\/ (Accessed 31 May 2022)."},{"issue":"12","key":"e_1_3_3_55_2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1471-0528.1983.tb06460.x","article-title":"Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha","volume":"90","author":"Lumsden MA","year":"1983","unstructured":"Lumsden MA, Kelly RW, Baird DT. Primary dysmenorrhoea: the importance of both prostaglandins E2 and F2 alpha. Br. J. Obstet. Gynaecol. 90(12), 1135\u20131140 (1983).","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"3","key":"e_1_3_3_56_2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0028-2243(90)90213-K","article-title":"Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives","volume":"36","author":"Creatsas G","year":"1990","unstructured":"Creatsas G Prostaglandins: PGF2 alpha, PGE2, 6-keto-PGF1 alpha and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptives. Eur. J. Obstet. Gynecol. Reprod. Biol. 36(3), 292\u2013298 (1990).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"6","key":"e_1_3_3_57_2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/humupd\/dmv039","article-title":"What we know about primary dysmenorrhea today: a critical review","volume":"21","author":"Iacovides S","year":"2015","unstructured":"Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a critical review. Hum. Reprod. Update 21(6), 762\u2013778 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0187"},{"issue":"1","key":"e_1_3_3_59_2","first-page":"518","article-title":"Transvaginal photobiomodulation for the treatment of chronic pelvic pain: a pilot study","volume":"2","author":"Zipper R","year":"2021","unstructured":"Zipper R, Pryor B, Lamvu G. Transvaginal photobiomodulation for the treatment of chronic pelvic pain: a pilot study. Womens Health Rep. (New Rochelle) 2(1), 518\u2013527 (2021).","journal-title":"Womens Health Rep. (New Rochelle)"},{"issue":"14","key":"e_1_3_3_60_2","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2021.14809","article-title":"Time for a \u2018pause\u2019 on the use of vaginal laser","volume":"326","author":"Adelman M","year":"2021","unstructured":"Adelman M, Nygaard IE. Time for a \u2018pause\u2019 on the use of vaginal laser. JAMA 326(14), 1378\u20131380 (2021).","journal-title":"JAMA"}],"container-title":["Journal of Comparative Effectiveness Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/becarispublishing.com\/doi\/pdf\/10.2217\/cer-2021-0281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T12:47:28Z","timestamp":1679230048000},"score":1,"resource":{"primary":{"URL":"https:\/\/becarispublishing.com\/doi\/10.2217\/cer-2021-0281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.2217\/cer-2021-0281"],"URL":"https:\/\/doi.org\/10.2217\/cer-2021-0281","relation":{},"ISSN":["2042-6305","2042-6313"],"issn-type":[{"value":"2042-6305","type":"print"},{"value":"2042-6313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}